β‐Elemene inhibits peritoneal metastasis of gastric cancer cells by modulating FAK/Claudin‐1 signaling

2019 ◽  
Vol 33 (9) ◽  
pp. 2448-2456 ◽  
Author(s):  
Mingming Deng ◽  
Ye Zhang ◽  
Bofang Liu ◽  
Yang Chen ◽  
Huicong Song ◽  
...  
Theranostics ◽  
2019 ◽  
Vol 9 (25) ◽  
pp. 7628-7647 ◽  
Author(s):  
Chao Wang ◽  
Min Shi ◽  
Jun Ji ◽  
Qu Cai ◽  
Jinling Jiang ◽  
...  

2016 ◽  
Vol 35 (5) ◽  
pp. 2624-2634 ◽  
Author(s):  
YUANYI XU ◽  
XIU JIN ◽  
YUNNING HUANG ◽  
JIANDA DONG ◽  
HONGHONG WANG ◽  
...  

2016 ◽  
Vol 11 (4) ◽  
pp. 2384-2390 ◽  
Author(s):  
YUANYI XU ◽  
YUNNING HUANG ◽  
HONGHONG WANG ◽  
YONG LIU

2012 ◽  
Vol 27 (9) ◽  
pp. 1037 ◽  
Author(s):  
Mi Ra Park ◽  
Ji Hee Lee ◽  
Myung Suk Park ◽  
Jun Eul Hwang ◽  
Hyun Jeong Shim ◽  
...  

Oncogene ◽  
2021 ◽  
Author(s):  
Xi Kang ◽  
Weilin Li ◽  
Weixin Liu ◽  
Han Liang ◽  
Jingyu Deng ◽  
...  

AbstractPeritoneal metastasis is a common form of metastasis among advanced gastric cancer patients. In this study, we reported the identification of LIM domain kinase 1 (LIMK1) as a promoter of gastric cancer peritoneal metastasis, and its potential to be a therapeutic target of dabrafenib (DAB). Using transcriptomic sequencing of paired gastric cancer peritoneal metastasis, primary tumors, and normal gastric tissues, we first unveiled that LIMK1 is selectively up-regulated in metastatic tumors. Increased LIMK1 in gastric cancer peritoneal metastasis was validated by immunohistochemistry analysis of an independent patient cohort. In vitro functional studies demonstrated that LIMK1 knockout or knockdown significantly inhibited cell migration and invasion of gastric cancer cells. LIMK1 knockout also abrogated peritoneal and liver metastases of gastric cancer cells in nude mice in vivo. Dabrafenib, a small molecule targeting LIMK1, was found to decrease cell migration and invasion of gastric cancer cells in vitro and abolish peritoneal and liver metastasis formation in vivo. Mechanistically, either LIMK1 knockout or Dabrafenib inhibited LIMK1 expression and phosphorylation of its downstream target cofilin. Taken together, our results demonstrated that LIMK1 functions as a metastasis promoter in gastric cancer by inhibiting LIMK1-p-cofilin and that Dabrafenib has the potential to serve as a novel treatment for gastric cancer peritoneal metastasis.


Oncology ◽  
2003 ◽  
Vol 64 (2) ◽  
pp. 176-182 ◽  
Author(s):  
Takuji Mori ◽  
Yoshiyuki Fujiwara ◽  
Masahiko Yano ◽  
Shigeyuki Tamura ◽  
Takushi Yasuda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document